Aduro Biotech Announces Clinical Program Update for Anti-APRIL Antibody BION-1301

World News: . []

BERKELEY Calif May 15 2019 GLOBE NEWSWIRE -- Aduro LINK  Inc NASDAQ ADRO a clinical-stage biopharmaceutical company LINK  on developing therapies targeting the Stimulator of Interferon Genes STING and A Proliferation LINK  Lig and (AP...

More news and information about Aduro BioTech, Inc.

Published By:

Globe Newswire: 22:05 GMT Wednesday 15th May 2019

Published: .

Search for other references to "aduro" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us